A journalist has filed a federal lawsuit against the FDA seeking documents related to the agency’s controversial approval last year of Exondys 51, a Duchenne muscular dystrophy treatment developed by Cambridge-based Sarepta Therapeutics.
Charles Seife, a journalist and professor at New York University, filed a complaint Thursday in Manhattan federal court challenging the FDA’s decision not to disclose records that he requested under the Freedom of Information Act.
The documents relate to the…
A journalist has filed a federal lawsuit against the FDA seeking documents related to the agency’s controversial approval last year of Exondys 51, a Duchenne muscular dystrophy treatment developed by Cambridge-based Sarepta Therapeutics.
Charles Seife, a journalist and professor at New York University, filed a complaint Thursday in Manhattan federal court challenging the FDA’s decision not to disclose records that he requested under the Freedom of Information Act.
The documents relate to the…